Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Clinical trial NCT03847818 · UNKNOWN
Trial details
- NCT number
- NCT03847818
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.